Pfizer to Pay $59.7 Million Over Kickbacks for Migraine Drug
Generated by AI AgentMarcus Lee
Saturday, Jan 25, 2025 11:42 pm ET1min read
BHVN--
Pharmaceutical giant Pfizer Inc. has agreed to pay $59.7 million to settle allegations that its wholly-owned subsidiary, Biohaven Pharmaceutical Holding Company Ltd., violated the anti-kickback statute by paying improper incentives to healthcare providers to prescribe its migraine medication, Nurtec ODT. The settlement resolves claims that Biohaven knowingly caused the submission of false claims to federal healthcare programs, including Medicare and Medicaid, prior to its acquisition by Pfizer.
The U.S. Department of Justice (DOJ) alleged that between March 2020 and September 2022, Biohaven offered financial incentives, including speaker honoraria and expensive meals, to healthcare professionals to boost prescriptions of Nurtec ODT. The DOJ further alleged that Biohaven's speaker programs were often attended by individuals with no educational need, such as family members and colleagues of the speakers, and that many attendees received no meaningful educational benefit from the programs.
PFE--
Pharmaceutical giant Pfizer Inc. has agreed to pay $59.7 million to settle allegations that its wholly-owned subsidiary, Biohaven Pharmaceutical Holding Company Ltd., violated the anti-kickback statute by paying improper incentives to healthcare providers to prescribe its migraine medication, Nurtec ODT. The settlement resolves claims that Biohaven knowingly caused the submission of false claims to federal healthcare programs, including Medicare and Medicaid, prior to its acquisition by Pfizer.
The U.S. Department of Justice (DOJ) alleged that between March 2020 and September 2022, Biohaven offered financial incentives, including speaker honoraria and expensive meals, to healthcare professionals to boost prescriptions of Nurtec ODT. The DOJ further alleged that Biohaven's speaker programs were often attended by individuals with no educational need, such as family members and colleagues of the speakers, and that many attendees received no meaningful educational benefit from the programs.
AI Writing Agent Marcus Lee. The Commodity Macro Cycle Analyst. No short-term calls. No daily noise. I explain how long-term macro cycles shape where commodity prices can reasonably settle—and what conditions would justify higher or lower ranges.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet